VTRO (Vitro Biopharma) FCF Yield %: -31.12 (As of Jun. 30, 2026)


What is Vitro Biopharma FCF Yield %?

Vitro Biopharma VTRO FCF Yield % is -31.12 as of Jun. 30, 2026. The stock has 6 warning signs investors should review.

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Vitro Biopharma's Trailing 12-Month Free Cash Flow is $0.00 Mil, and Market Cap is $0.00 Mil. Therefore, Vitro Biopharma's FCF Yield % for today is -31.12%.

The historical rank and industry rank for Vitro Biopharma's FCF Yield % or its related term are showing as below:

VTRO' s FCF Yield % Range Over the Past 10 Years
Min: -18.03   Med: -7.53   Max: -2.62
Current: -31.12

During the past 13 years, the highest FCF Yield % of Vitro Biopharma was -2.62%. The lowest was -18.03%. And the median was -7.53%.

VTRO's FCF Yield % is not ranked
in the Biotechnology industry.
Industry Median: -9.49 vs VTRO: -31.12

Vitro Biopharma's FCF Margin % for the quarter that ended in Oct. 2022 was -76.74%.

Vitro Biopharma FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Vitro Biopharma FCF Yield % Related Terms

Vitro Biopharma FCF Yield % Historical Data

* Premium members only.

The historical data trend for Vitro Biopharma's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vitro Biopharma FCF Yield % Chart

Vitro Biopharma Annual Data
Trend Oct09 Oct10 Oct11 Oct12 Oct13 Oct14 Oct15 Oct17 Oct21 Oct22
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Vitro Biopharma Quarterly Data
Oct00 Oct01 Oct02 Oct03 Oct04 Oct05 Oct06 Oct07 Oct08 Oct09 Oct10 Oct11 Oct12 Oct13 Oct14 Oct15 Oct17 Oct21 Oct22
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

VTRO vs : FCF Yield % Comparison

For the Biotechnology subindustry, Vitro Biopharma's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vitro Biopharma FCF Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vitro Biopharma's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Vitro Biopharma's FCF Yield % falls into.


Vitro Biopharma FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Vitro Biopharma's FCF Yield % for the fiscal year that ended in Oct. 2022 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-2.527 / 0
=N/A%

Vitro Biopharma's annualized FCF Yield % for the quarter that ended in Oct. 2022 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-2.527 * 4 / 0
=N/A%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Yield % →
What does a FCF Yield % of -31.12 mean?
Vitro Biopharma (VTRO) has a FCF Yield % of -31.12 as of Jun. 30, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Vitro Biopharma and its competitors.
Is Vitro Biopharma's FCF Yield % too high?
Vitro Biopharma's current FCF Yield % is -31.12.
How does Vitro Biopharma's FCF Yield % compare to ?
Vitro Biopharma's FCF Yield % of -31.12 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Biotechnology company?
A good FCF Yield % depends on the Biotechnology industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Vitro Biopharma and its competitors. Vitro Biopharma's current FCF Yield % is -31.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vitro Biopharma stock overvalued right now?
Vitro Biopharma (VTRO) has a current FCF Yield % of -31.12. The current FCF Yield % is -31.12. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Vitro Biopharma (VTRO), the current FCF Yield % is -31.12 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Vitro Biopharma Business Description

Comparable Companies
Address 4621 Technology Drive, Golden, CO, USA, 80403
Vitro Diagnostics Inc is a US-based company, which is dedicated to providing high-quality commercialized cell lines, media, and stem cell technology for applications in stem cell research, drug discovery, and therapies. In addition, it also provides tools for clinical development focused on Mesenchymal Stem Cells (MSCs). Further, it offers cancer-associated fibroblasts (CAFs), which are used in the discovery of a new type of CAFs present in pancreatic cancer tumors, called pancreatic stellate cells. Geographically business activities are functioned through the region of United States.